Gene expression of 5-lipoxygenase and LTA4 hydrolase in renal tissue of nephrotic syndrome patients.
Leukotrienes (LT) of the 5-lipoxygenase pathway constitute a class of potent biological lipid mediators of inflammation implicated in the pathogenesis of different models of experimental glomerulonephritis. The key enzyme, 5-lipoxygenase (5-LO), catalyses oxygenation of arachidonic acid to generate the primary leukotriene LTA4. This LT, in turn, serves as a substrate for either LTA4 hydrolase, to form the potent chemoattractant LTB4, or LTC4 synthase, to produce the powerful vasoconstrictor LTC4. To investigate the potential role of LT in the pathogenesis of human glomerulonephritis with nephrotic syndrome, we examined the gene expression of 5-LO and LTA4 hydrolase in renal tissue of 21 adult patients with nephrotic syndrome and 11 controls. The patients consisted of 11 cases of membranous nephropathy (MN), seven focal and segmental glomerulosclerosis (FSGS), two non-IgA mesangial glomerulonephritis and one minimal change disease. Total RNA purified from renal tissue was reverse transcribed into cDNA and amplified with specific primers in a polymerase chain reaction (RT-PCR). Eight patients' renal tissue, four MN and four FSGS, co-expressed 5-LO and LTA4 hydrolase. In situ hybridization analysis revealed 5-LO expression and distribution limited to the interstitial cells surrounding the peritubular capillaries. Comparative clinical and immunohistological data showed that these eight patients had impaired renal function and interstitial changes that significantly correlated with 5-LO expression. These findings suggest that leukotrienes may play an important role in the pathogenesis of MN and FSGS. These results are also relevant to elucidating the pathophysiologic mechanisms which underlie progression to renal failure in these diseases.
Menegatti
E
E
Dipartimento di Medicina e Oncologia Sperimentale e, Isituto di Nefro-Urologia, Universitá di Torino, Italy.
Roccatello
D
D
Fadden
K
K
Piccoli
G
G
De Rosa
G
G
Sena
L M
LM
Rifai
A
A
D000328:Adult; D000368:Aged; D018941:Antigens, CD19 / Q000032:analysis; D001094:Arachidonate 5-Lipoxygenase / Q000235:genetics*; D004851:Epoxide Hydrolases / Q000235:genetics*; D015870:Gene Expression; D005919:Glomerular Filtration Rate; D015433:Glomerulonephritis, Membranous / Q000201:enzymology / Q000209:etiology / Q000628:therapy; D005923:Glomerulosclerosis, Focal Segmental / Q000201:enzymology / Q000209:etiology / Q000628:therapy; D006801:Humans; D007668:Kidney / Q000201:enzymology*; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000201:enzymology*
D018941:Antigens, CD19; D001094:Arachidonate 5-Lipoxygenase; D004851:Epoxide Hydrolases; C043134:leukotriene A4 hydrolase